PHILOGEN S.P.A.
Patent Owner
Stats
- 26 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 20, 2018 most recent publication
Details
- 26 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 306 Total Citation Count
- May 23, 1997 Earliest Filing
- 16 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0200,789 IL4 CONJUGATED TO ANTIBODIES AGAINST EXTRACELLULAR MATRIX COMPONENTSFeb 28, 14Jul 14, 16[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9896503 Antigen associated with the neovasculature of tumour metastasesOct 05, 15Feb 20, 18[A61K, C07K]
9527907 Antigens associated with endometriosis, psoriatic arthritis and psoriasisDec 28, 09Dec 27, 16[A61K, C07K]
9289470 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpartJun 17, 14Mar 22, 16[A61K, A61P, C07K]
9181347 Antigen associated with the neovasculature of tumour metastasesJul 03, 13Nov 10, 15[A61K, C07K]
9096670 Antibodies of the ED-B domain of fibronectin, their construction and usesOct 04, 13Aug 04, 15[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0030,536 ANTIGEN ASSOCIATED WITH LUNG CANCERS AND LYMPHOMASAbandonedAug 11, 14Jan 29, 15[A61K, C07K]
2014/0348,784 COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONSAbandonedJun 05, 14Nov 27, 14[A61K]
2014/0341,844 IMMUNOCYTOKINES IN COMBINATION WITH ANTI-ERBB ANTIBODIES FOR THE TREATMENT OF CANCERAbandonedAug 04, 14Nov 20, 14[A61K]
8580267 Immunocytokines for tumour therapy with chemotherapeutic agentsExpiredDec 14, 09Nov 12, 13[A61K, A01N]
2013/0266,511 NOVEL ANTIGEN ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASESAbandonedJun 06, 13Oct 10, 13[A61K, C07K]
2013/0108,581 Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic AgentsAbandonedNov 16, 12May 02, 13[A61K]
2012/0107,270 Immunocytokines In Combination With Anti-ErbB Antibodies For The Treatment Of CancerAbandonedJun 25, 10May 03, 12[A61K, A61P]
2011/0020,224 APPARATUS AND METHOD FOR PREPARING MEDICINES CONTAINING RADIOACTIVE SUBSTANCESAbandonedApr 16, 09Jan 27, 11[A61K, A61P, G21C]
2010/0215,615 IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTSAbandonedJun 25, 08Aug 26, 10[A61K, C07D, A61P, C07K]
2010/0183,506 ANTIGEN ASSOCIATED WITH LUNG CANCERS AND LYMPHOMASAbandonedJul 24, 08Jul 22, 10[A61K, G01N, A61P]
2009/0117,073 USE OF A FUSION PROTEIN TARGETING THE ED-B FIBRONECTIN DOMAIN FOR TREATMENT OF ATHEROSCLEROSISAbandonedOct 30, 07May 07, 09[A61K]
2005/0112,690 Binding molecules for the extra-domain B of fibronectin for detection of arteriosclerotic plaqueAbandonedOct 18, 04May 26, 05[G01N]
2005/0074,401 Selective targeting of tumor vasculature using radiolabelled antibody moleculesAbandonedSep 10, 04Apr 07, 05[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.